Anticancer efficacy of a nitric oxide‐modified derivative of bifendate against multidrug‐resistant cancer cells

The development of multidrug resistance (MDR) not only actively transports a wide range of cytotoxic drugs across drug transporters but is also a complex interaction between a number of important cellular signalling pathways. Nitric oxide donors appear to be a new class of anticancer therapeutics fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Zhiguang, Gu, Xiaoke, Lu, Bin, Chen, Yaqiong, Chen, Guojiang, Feng, Jiannan, Lin, Jizhen, Zhang, Yihua, Peng, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882976/
https://www.ncbi.nlm.nih.gov/pubmed/26864945
http://dx.doi.org/10.1111/jcmm.12796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882976/
https://www.ncbi.nlm.nih.gov/pubmed/26864945
http://dx.doi.org/10.1111/jcmm.12796

Ejemplares similares